The medtechs that enjoy the highest sales for their headcount tend to be those making large, expensive machines or largely genericised orthopaedic implants – the types of product that tend to require relatively little in the way of R&D expenditure. But these devices are heavily used in elective procedures, and this is exactly where demand has cratered so far this year thanks to the pandemic.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,